Exprimo

Exprimo is a specialized contract research organization (CRO) that provides pharmacometrics and model-based drug development services to the global pharmaceutical and biotechnology industries. Founded in 2002 and headquartered in Belgium, the company focuses on using advanced mathematical modeling and simulation to optimize clinical trial designs and support regulatory decision-making. Their expertise spans population pharmacokinetics (PopPK), pharmacodynamics (PK/PD), and disease progression modeling. In 2015, Exprimo was acquired by Certara, integrating its high-end consulting services into Certara's broader drug development software and services portfolio.